Description
A sphingolipid; upregulated in the hippocampus of rats with streptozotocin-induced diabetes; positively correlated with insulin resistance in obese humans; upregulated in the liver of a mouse model of Niemann-Pick type C1 disease; plasma concentration is decreased in men with prostate cancer
Formal name: 4-hydroxy-7S-[(1R,2E)-1-hydroxy-2-hexadecen-1-yl]-N,N,N-trimethyl-9-oxo-3,5-dioxa-8-aza-4-phosphaoctacosan-1-aminium, 4-oxide, inner salt
Synonyms: N-eicosanoyl-D-erythro-Sphingosylphosphorylcholine|SM(d18:1/20:0)
Molecular weight: 759.2
CAS: 121999-68-6
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cancer||Research Area|Endocrinology & Metabolism|Inborn Errors of Metabolism||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Obesity||Research Area|Lipid Biochemistry|Sphingolipids